SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--Robert Shahverdyan, MD, Head of the Vascular Access Center at Asklepios Klinik Barmbek in Hamburg, Germany, presented his experience performing ...
The FDA-approved Ellipsys® Vascular Access System from Avenu Medical, Inc., became a key focus of attention throughout last week's Controversies in Dialysis Access (CiDA) 15 th Anniversary Meeting, ...
WASHINGTON--(BUSINESS WIRE)--The FDA-approved Ellipsys® Vascular Access System from Avenu Medical, Inc., became a key focus of attention throughout last week’s Controversies in Dialysis Access (CiDA) ...
San Juan Capistrano, Calif. - A landmark two-year follow-up study on the Ellipsys® Vascular Access System was highlighted at the annual Controversies in Dialysis Access (CiDA) meeting, one of the ...
A new healthcare analysis shows that a catheter-based endovascular system for creating hemodialysis access offers significant quality-of-life benefits and cost savings compared to the traditional ...
A Bradenton clinic is offering a new nonsurgical procedure to prepare patients for kidney dialysis. Dr. Jenna Kazil started using the new WavelinQ EndoAVF System in January at the Florida Surgical ...
AUSTIN, Texas, Sept. 27, 2017 /PRNewswire/ -- TVA Medical, Inc., a medical device company developing innovative therapies for end-stage renal disease (ESRD), today announced that its everlinQ TM 4 ...
TVA Medical, Inc., a medical device company developing innovative therapies for end-stage renal disease (ESRD), announced that its everlinQ 4 endoAVF System has received CE Mark in the European Union.
Today, the U.S. Food and Drug Administration permitted marketing of two catheter-based devices designed to create a connection to veins and arteries in patients with chronic kidney disease who need ...
4 French catheter system creates an endovascular hemodialysis access with a streamlined procedure AUSTIN, Texas, Sept. 27, 2017 /PRNewswire/ -- TVA Medical, Inc., a medical device company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results